These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 25562196)

  • 21. A multiplex immunoassay for the non-invasive detection of bladder cancer.
    Shimizu Y; Furuya H; Bryant Greenwood P; Chan O; Dai Y; Thornquist MD; Goodison S; Rosser CJ
    J Transl Med; 2016 Jan; 14():31. PubMed ID: 26830497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary extracellular vesicles-encapsulated miRNA signatures: A new paradigm for urinary bladder cancer diagnosis and classification.
    Kural S; Jain G; Agarwal S; Das P; Kumar L
    Urol Oncol; 2024 Jul; 42(7):179-190. PubMed ID: 38594151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary levels of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein as a diagnostic biomarker in patients with bladder cancer.
    Nitta Y; Konishi H; Makino T; Tanaka T; Kawashima H; Iovanna JL; Nakatani T; Kiyama H
    BMC Urol; 2012 Sep; 12():24. PubMed ID: 22943287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery and validation of potential urinary biomarkers for bladder cancer diagnosis using a pseudotargeted GC-MS metabolomics method.
    Zhou Y; Song R; Ma C; Zhou L; Liu X; Yin P; Zhang Z; Sun Y; Xu C; Lu X; Xu G
    Oncotarget; 2017 Mar; 8(13):20719-20728. PubMed ID: 28157703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomic analysis of urinary and tissue-exudative extracellular vesicles to discover novel bladder cancer biomarkers.
    Tomiyama E; Matsuzaki K; Fujita K; Shiromizu T; Narumi R; Jingushi K; Koh Y; Matsushita M; Nakano K; Hayashi Y; Wang C; Ishizuya Y; Kato T; Hatano K; Kawashima A; Ujike T; Uemura M; Takao T; Adachi J; Tomonaga T; Nonomura N
    Cancer Sci; 2021 May; 112(5):2033-2045. PubMed ID: 33721374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary evaluation of urinary soluble Met as a biomarker for urothelial carcinoma of the bladder.
    McNeil BK; Sorbellini M; Grubb RL; Apolo A; Cecchi F; Athauda G; Cohen B; Giubellino A; Simpson H; Agarwal PK; Coleman J; Getzenberg RH; Netto GJ; Shih J; Linehan WM; Pinto PA; Bottaro DP
    J Transl Med; 2014 Oct; 12():199. PubMed ID: 25335552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary MicroRNAs as Potential Markers for Non-Invasive Diagnosis of Bladder Cancer.
    Erdmann K; Salomo K; Klimova A; Heberling U; Lohse-Fischer A; Fuehrer R; Thomas C; Roeder I; Froehner M; Wirth MP; Fuessel S
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and validation of methylated PENK gene for early detection of bladder cancer using urine DNA.
    Oh TJ; Lim E; Bang BR; Lee JJ; Na YG; Shin JH; Lim JS; Song KH; An S
    BMC Cancer; 2022 Nov; 22(1):1195. PubMed ID: 36403035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic Pathway Signatures Associated with Urinary Metabolite Biomarkers Differentiate Bladder Cancer Patients from Healthy Controls.
    Kim WT; Yun SJ; Yan C; Jeong P; Kim YH; Lee IS; Kang HW; Park S; Moon SK; Choi YH; Choi YD; Kim IY; Kim J; Kim WJ
    Yonsei Med J; 2016 Jul; 57(4):865-71. PubMed ID: 27189278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer.
    Shimizu T; Suzuki H; Nojima M; Kitamura H; Yamamoto E; Maruyama R; Ashida M; Hatahira T; Kai M; Masumori N; Tokino T; Imai K; Tsukamoto T; Toyota M
    Eur Urol; 2013 Jun; 63(6):1091-100. PubMed ID: 23200812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas.
    Kodama H; Yoneyama T; Tanaka T; Noro D; Tobisawa Y; Yamamoto H; Suto S; Hatakeyama S; Mori K; Yoneyama T; Hashimoto Y; Kakizaki I; Nakaji S; Ohyama C
    Cancer Med; 2021 Feb; 10(4):1297-1313. PubMed ID: 33455069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HR-MAS NMR tissue metabolomic signatures cross-validated by mass spectrometry distinguish bladder cancer from benign disease.
    Tripathi P; Somashekar BS; Ponnusamy M; Gursky A; Dailey S; Kunju P; Lee CT; Chinnaiyan AM; Rajendiran TM; Ramamoorthy A
    J Proteome Res; 2013 Jul; 12(7):3519-28. PubMed ID: 23731241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multiplex urinary immunoassay for bladder cancer detection: analysis of a Japanese cohort.
    Goodison S; Ogawa O; Matsui Y; Kobayashi T; Miyake M; Ohnishi S; Fujimoto K; Dai Y; Shimizu Y; Tsukikawa K; Furuya H; Rosser CJ
    J Transl Med; 2016 Oct; 14(1):287. PubMed ID: 27717367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolite marker discovery for the detection of bladder cancer by comparative metabolomics.
    Shao CH; Chen CL; Lin JY; Chen CJ; Fu SH; Chen YT; Chang YS; Yu JS; Tsui KH; Juo CG; Wu KP
    Oncotarget; 2017 Jun; 8(24):38802-38810. PubMed ID: 28415579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bladder cancer biomarker array to detect aberrant levels of proteins in urine.
    Gogalic S; Sauer U; Doppler S; Preininger C
    Analyst; 2015 Feb; 140(3):724-35. PubMed ID: 25427191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Urinary MicroRNAs as Potential Biomarkers of Bladder Cancer].
    Juráček J; Staník M; Peltanová B; Adamcová S; Doležel J; Fedorko M; Radová L; Slabý O
    Klin Onkol; 2018; 31(Supplementum1):155-157. PubMed ID: 29808692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-8 as a urinary biomarker for the detection of bladder cancer.
    Urquidi V; Chang M; Dai Y; Kim J; Wolfson ED; Goodison S; Rosser CJ
    BMC Urol; 2012 May; 12():12. PubMed ID: 22559832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry.
    Issaq HJ; Nativ O; Waybright T; Luke B; Veenstra TD; Issaq EJ; Kravstov A; Mullerad M
    J Urol; 2008 Jun; 179(6):2422-6. PubMed ID: 18433783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urine BLCA-4 exerts potential role in detecting patients with bladder cancers: a pooled analysis of individual studies.
    Cai Q; Wu Y; Guo Z; Gong R; Tang Y; Yang K; Li X; Guo X; Niu Y; Zhao Y
    Oncotarget; 2015 Nov; 6(35):37500-10. PubMed ID: 26462026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary cell-free microRNA-106b as a novel biomarker for detection of bladder cancer.
    Zhou X; Zhang X; Yang Y; Li Z; Du L; Dong Z; Qu A; Jiang X; Li P; Wang C
    Med Oncol; 2014 Oct; 31(10):197. PubMed ID: 25168920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.